Deborah Holder
Neurology with Special Qualifications in Child Neurology · Los Angeles, CANPI 1326011040
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $105,573 of the $130,023 with a category attached, or 81.2%. Livanova USA, Inc. accounts for 95.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $31,315 and has fallen 59.6% since, to $12,637 in 2025. Among neurology with special qualifications in child neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $977.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$124K
- Immedica Pharma US, Inc.$5K
- Neuropace, Inc.$935
- Jazz Pharmaceuticals Inc.$253
- Life Molecular Imaging Ltd$91
- UCB, Inc.$45
- plus $2 from 1 others
Across 29 payments — averaging $286.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$8K
- Jazz Pharmaceuticals Inc.$521
What the payments were for
- Consulting fees$4,7854%
- Speaking & faculty fees$105,57381%
- Travel & lodging$11,4769%
- Food & beverage$8,1876%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 113 | $123,913 |
| Immedica Pharma US, Inc. | 1 | $4,785 |
| Neuropace, Inc. | 8 | $935 |
| Jazz Pharmaceuticals Inc. | 4 | $253 |
| Life Molecular Imaging Ltd | 4 | $91 |
| UCB, Inc. | 1 | $45 |
| Travere Therapeutics, Inc. | 2 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$56,788
- VNS Therapy$50,135
- VNS - Sentiva$15,791
- RNS Neurostimulator Kit$750
How this compares
$130,023 in reported general payments places this provider in the 95th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in Los Angeles
- Rajsekar RajaramanLos Angeles$134K
- Leigh Maria Ramos PlattLos Angeles$59K
- Shaun HussainLos Angeles$40K
- Mohsen HamzaLos Angeles$24K
- Tena RosserLos Angeles$7K
- Arthur PartikianLos Angeles$7K
- Michael ChezSacramento$374K
- Allen BottOakland$372K
- Joseph SullivanSan Francisco$240K
- Ann SegerenStanford$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.